Joint relationship between renal function and proteinuria on mortality of patients with type 2 diabetes: The Taichung Diabetes Study

Cardiovascular Diabetology

Volumn 11, Issue , 2012, Pages

  Lin, Cheng Chieh ^a,b   Chen, Ching Chu ^a   Kung, Pei Tseng ^c   Li, Chia Ing ^a,b   Yang, Sing Yu ^d   Liu, Chiu Shong ^a,b   Lin, Wen Yuan ^a,b   Lee, Cheng Chun ^a,b   Li, Tsai Chung ^c,d   Kardia, Sharon L R ^e,f  

^a CHINA MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^b CHINA MEDICAL UNIVERSITY   (Taiwan)

^c ASIA UNIVERSITY   (Taiwan)

^d CHINA MEDICAL UNIVERSITY   (Taiwan)

^e CHINA MEDICAL UNIVERSITY   (Taiwan)

^f UNIVERSITY OF MICHIGAN   (United States)

Author keywords

Mortality; Renal function; Type 2 diabetes

Indexed keywords

ADULT; ARTICLE; CARDIOVASCULAR DISEASE; CARDIOVASCULAR MORTALITY; ESTIMATED GLOMERULAR FILTRATION RATE; FEMALE; FOLLOW UP; GLOMERULUS FILTRATION RATE; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; NON INSULIN DEPENDENT DIABETES MELLITUS; PROSPECTIVE STUDY; PROTEINURIA;

ADULT; AGED; CARDIOVASCULAR DISEASES; CAUSE OF DEATH; DIABETES MELLITUS, TYPE 2; DIABETIC NEPHROPATHIES; FEMALE; GLOMERULAR FILTRATION RATE; HUMANS; KAPLAN-MEIER ESTIMATE; KIDNEY; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; PROSPECTIVE STUDIES; PROTEINURIA; REAGENT STRIPS; REGISTRIES; RISK ASSESSMENT; RISK FACTORS; TAIWAN; TIME FACTORS; URINALYSIS;

EID: 84867618715     PISSN: None     EISSN: 14752840     Source Type: Journal    
DOI: 10.1186/1475-2840-11-131     Document Type: Article

References (39)

1. Levin A, Djurdjev O, Barrett B, Burgess E, Carlisle E, Ethier J, Jindal K, Mendelssohn D, Tobe S, Singer J, Thompson C. Cardiovascular disease in patients with chronic kidney disease: getting to the heart of the matter. Am J Kidney Dis. 2001, 38(6):1398-1407. 10.1053/ajkd.2001.29275, 11728982.
2. Colhoun HM, Lee ET, Bennett PH, Lu M, Keen H, Wang SL, Stevens LK, Fuller JH. Risk factors for renal failure: the WHO Multinational Study of Vascular Disease in Diabetes. Diabetologia 2001, 44(Suppl. 2):S46-S53.
3. Culleton BF, Wilson PWF. Thrombogenic risk factors for cardiovascular disease in dialysis patients. Sem Dial. 1999, 12(2):117-125.
4. US Renal Data System USRDS 2004 annual data report. Am J Kidney Dis 2005, 45:S8-S80. US Renal Data System.
5. Nishida Y, Takahashi Y, Nakayama T, Soma M, Asai S. Comparative effect of olmesartan and candesartan on lipid metabolism and renal function in patients with hypertension: a retrospective observational study. Cardiovasc Diabetol 2011, 10:74. 10.1186/1475-2840-10-74, 3163179, 21827713.
6. Mallat SG. What is a preferred angiotensin II receptor blocker-based combination therapy for blood pressure control in hypertensive patients with diabetic and non-diabetic renal impairment?. Cardiovasc Diabetol 2012, 11:32. 10.1186/1475-2840-11-32, 3351968, 22490507.
7. Kuo HW, Tsai SS, Tiao MM, Yang CY. Epidemiological features of CKD in Taiwan. Am J Kidney Dis 2007, 49(1):46-55. 10.1053/j.ajkd.2006.10.007, 17185145.
8. Chang C, Lu F, Yang YC, Wu JS, Wu TJ, Chen MS, Chuang LM, Tai TY. Epidemiologic study of type 2 diabetes in Taiwan. Diabetes Res Clin Pract 2000, 50(2):S49-S59.
9. Janus ED, Watt NM, Lam KS, Cockram CS, Siu ST, Liu LJ, Lam TH. The prevalence of diabetes, association with cardiovascular risk factors and implications of diagnostic criteria (ADA 1997 and WHO 1998) in a 1996 community-based population study in Hong Kong Chinese. Hong Kong Cardiovascular Risk Factor Steering Committee. American Diabetes Association. Diabet Med 2000, 17:741-745. 10.1046/j.1464-5491.2000.00376.x, 11110508.
10. Gu D, Reynolds K, Duan X, Xin X, Chen J, Wu X, Mo J, Whelton PK, He J, . InterASIA Collaborative Group Prevalence of diabetes and impaired fasting glucose in the Chinese adult population: International Collaborative Study of Cardiovascular Disease in Asia (InterASIA). Diabetologia 2003, 46:1190-1198. 10.1007/s00125-003-1167-8, 12879248, InterASIA Collaborative Group.
11. Wong KC, Wang Z. Prevalence of type 2 diabetes mellitus of Chinese populations in Mainland China, Hong Kong, and Taiwan. Diabetes Res Clin Pract 2006, 73:126-134. 10.1016/j.diabres.2006.01.007, 16563548.
12. Gomez-Marcos MA, Recio-Rodríguez JI, Patino-Alonso MC, Agudo-Conde C, Gomez-Sanchez L, Rodriguez-Sanchez E, Gomez-Sanchez M, Garcia-Ortiz L. Yearly evolution of organ damage markers in diabetes or metabolic syndrome: data from the LOD-DIABETES study. Cardiovasc Diabetol 2011, 10:90. 10.1186/1475-2840-10-90, 3214163, 21999369.
13. Fox CS, Matsushita K, Woodward M, Bilo HJ, Chalmers J, Heerspink HJ, Lee BJ, Perkins RM, Rossing P, Sairenchi T, Tonelli M, Vassalotti JA, Yamagishi K, Coresh J, de Jong PE, Wen CP, Nelson RG. For the Chronic Kidney Disease Prognosis Consortium: Associations of kidney disease measures with mortality and end-stage renal disease in individuals with and without diabetes: a meta-analysis. Lancet 2012, pii: S0140-6736(12):61350-6.
14. Berhane AM, Weil EJ, Knowler WC, Nelson RG, Hanson RL. Albuminuria and estimated glomerular filtration rate as predictors of diabetic end-stage renal disease and death. Clin J Am SocNephrol 2011, 6:2444-2451.
15. Schou M, Torp-Pedersen C, Gustafsson F, Abdulla J, Kober L. Wall motion index, estimated glomerular filtration rate and mortality risk in patients with heart failure or myocardial infarction: a pooled analysis of 18,010 patients. Eur J Hear Fail 2008, 10(7):682-688.
16. Smith GL, Shlipak MG, Havranek EP, Foody JM, Masoudi FA, Rathore SS, Krumholz HM. Serum urea nitrogen, creatinine, and estimators of renal function: mortality in older patients with cardiovascular disease. Arch Intern Med 2006, 166(10):1134-1142. 10.1001/archinte.166.10.1134, 16717177.
17. Hillege HL, Nitsch D, Pfeffer MA, Swedberg K, McMurray JJ, Yusuf S, Granger CB, Michelson EL, Ostergren J, Cornel JH, de Zeeuw D, Pocock S, Van Veldhuisen DJ, . Candesartan in Heart Failure: Assessment of Reduction in Mortality and Morbidity (CHARM) Investigators Renal function as a predictor of outcome in a broad spectrum of patients with heart failure. Circulation 2006, 113(5):671-678. 10.1161/CIRCULATIONAHA.105.580506, 16461840, Candesartan in Heart Failure: Assessment of Reduction in Mortality and Morbidity (CHARM) Investigators.
18. Diez C, Mohr P, Koch D, Silber RE, Schmid C, Hofmann HS. Age- and gender-specific values of estimated glomerular filtration rate among 6232 patients undergoing cardiac surgery. Interact Cardiovasc Thorac Surg 2009, 9(4):593-597. 10.1510/icvts.2009.208033, 19584070.
19. Lin Y, Zheng Z, Li Y, Yuan X, Hou J, Zhang S, Fan H, Wang Y, Li W, Hu S. Impact of renal dysfunction on long-term survival after isolated coronary artery bypass surgery. Ann Thorac Surg 2009, 87(4):1079-1084. 10.1016/j.athoracsur.2009.01.065, 19324131.
20. Brown JR, Cochran RP, MacKenzie TA, Furnary AP, Kunzelman KS, Ross CS, Langner CW, Charlesworth DC, Leavitt BJ, Dacey LJ, Helm RE, Braxton JH, Clough RA, Dunton RF, O'Connor GT, . Northern New England Cardiovascular Disease Study Group Long-term survival after cardiac surgery is predicted by estimated glomerular filtration rate. Ann Thorac Surg 2008, 86(1):4-11. 10.1016/j.athoracsur.2008.03.006, 18573389, Northern New England Cardiovascular Disease Study Group.
21. He X, Moore J, Shabir S, Little MA, Cockwell P, Ball S, Liu X, Johnston A, Borrows R. Comparison of the predictive performance of eGFR formulae for mortality and graft failure in renal transplant recipients. Transplantation 2009, 87(3):384-392. 10.1097/TP.0b013e31819004a1, 19202443.
22. Conway B, Webster A, Ramsay G, Morgan N, Neary J, Whitworth C, Harty J. Predicting mortality and uptake of renal replacement therapy in patients with stage 4 chronic kidney disease. Nephrol Dial Transplant 2009, 24(6):1930-1937. 10.1093/ndt/gfn772, 19181760.
23. Hemmelgarn BR, Manns BJ, Lloyd A, James MT, Klarenbach S, Quinn RR, Wiebe N, Tonelli M, . Alberta Kidney Disease Network Relation between kidney function, proteinuria, and adverse outcomes. JAMA 2010, 303(5):423-429. 10.1001/jama.2010.39, 20124537, Alberta Kidney Disease Network.
24. James MT, Quan H, Tonelli M, Manns BJ, Faris P, Laupland KB, Hemmelgarn BR, . Alberta Kidney Disease Network CKD and risk of hospitalization and death with pneumonia. Am J Kidney Dis 2009, 54(1):24-32. 10.1053/j.ajkd.2009.04.005, 19447535, Alberta Kidney Disease Network.
25. Roderick PJ, Atkins RJ, Smeeth L, Mylne A, Nitsch DD, Hubbard RB, Bulpitt CJ, Fletcher AE. CKD and mortality risk in older people: a community-based population study in the United Kingdom. Am J Kidney Dis 2009, 53(6):950-960. 10.1053/j.ajkd.2008.12.036, 19394727.
26. Pizzarelli F, Lauretani F, Bandinelli S, Windham GB, Corsi AM, Giannelli SV, Ferrucci L, Guralnik JM. Predictivity of survival according to different equations for estimating renal function in community-dwelling elderly subjects. Nephrol Dial Transplant 2009, 24(4):1197-1205. 2721425, 18988669.
27. Weiner DE, Krassilnikova M, Tighiouart H, Salem DN, Levey AS, Sarnak MJ. CKD classification based on estimated GFR over three years and subsequent cardiac and mortality outcomes: a cohort study. BMC Nephrol 2009, 10:26. 10.1186/1471-2369-10-26, 2760546, 19761597.
28. Cheng TY, Wen SF, Astor BC, Tao XG, Samet JM, Wen CP. Mortality risks for all causes and cardiovascular diseases and reduced GFR in a middle-aged working population in Taiwan. Am J Kidney Dis 2008, 52(6):1051-1060. 10.1053/j.ajkd.2008.05.030, 18706747.
29. So WY, Kong AP, Ma RC, Ozaki R, Szeto CC, Chan NN, Ng V, Ho CS, Lam CW, Chow CC, Cockram CS, Chan JC, Tong PC. Glomerular filtration rate, cardiorenal end points, and all-cause mortality in type 2 diabetic patients. Diabetes Care 2006, 29(9):2046-2052. 10.2337/dc06-0248, 16936151.
30. Bruno G, Merletti F, Bargero G, Novelli G, Melis D, Soddu A, Perotto M, Pagano G, Cavallo-Perin P. Estimated glomerular filtration rate, albuminuria and mortality in type 2 diabetes: the Casale Monferrato study. Diabetologia 2007, 50(5):941-948. 10.1007/s00125-007-0616-1, 17333106.
31. Nag S, Bilous R, Kelly W, Jones S, Roper N, Connolly V. All-cause and cardiovascular mortality in diabetic subjects increases significantly with reduced estimated glomerular filtration rate (eGFR): 10 years' data from the South Tees Diabetes Mortality study. Diabet Med 2007, 24(1):10-17. 10.1111/j.1464-5491.2007.02023.x, 17227319.
32. Ninomiya T, Perkovic V, de Galan BE, Zoungas S, Pillai A, Jardine M, Patel A, Cass A, Neal B, Poulter N, Mogensen CE, Cooper M, Marre M, Williams B, Hamet P, Mancia G, Woodward M, Macmahon S, Chalmers J, . ADVANCE Collaborative Group Albuminuria and kidney function independently predict cardiovascular and renal outcomes in diabetes. J Am Soc Nephrol 2009, 20(8):1813-1821. 10.1681/ASN.2008121270, 2723977, 19443635, ADVANCE Collaborative Group.
33. Anavekar NS, Gans DJ, Berl T, Rohde RD, Cooper W, Bhaumik A, Hunsicker LG, Rouleau JL, Lewis JB, Rosendorff C, Porush JG, Drury PL, Esmatjes E, Raz I, Vanhille P, Locatelli F, Goldhaber S, Lewis EJ, Pfeffer MA. Predictors of cardiovascular events in patients with type 2 diabetic nephropathy and hypertension: a case for albuminuria. Kidney Int Suppl 2004, 92:S50-S55.
34. National Kidney Foundation K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Am J Kidney Dis 2002, 39(2 Suppl 1):S1-S266. National Kidney Foundation.
35. Xie Y, Chen X. Epidemiology, major outcomes, risk factors, prevention and management of chronic kidney disease in China. Am J Nephrol 2008, 28(1):1-7. 10.1159/000108755, 17890852.
36. Wen CP, Cheng TY, Tsai MK, Chang YC, Chan HT, Tsai SP, Chiang PH, Hsu CC, Sung PK, Hsu YH, Wen SF. All-cause mortality attributable to chronic kidney disease: a prospective cohort study based on 462 293 adults in Taiwan. Lancet 2008, 371(9631):2173-2182. 10.1016/S0140-6736(08)60952-6, 18586172.
37. Sarnak MJ, Levey AS, Schoolwerth AC, Coresh J, Culleton B, Hamm LL, McCullough PA, Kasiske BL, Kelepouris E, Klag MJ, Parfrey P, Pfeffer M, Raij L, Spinosa DJ, Wilson PW, . American Heart Association Councils on Kidney in Cardiovascular Disease, High Blood Pressure Research, Clinical Cardiology, and Epidemiology and Prevention Kidney disease as a risk factor for development of cardiovascular disease: a statement from the American Heart Association Councils on Kidney in Cardiovascular Disease, High Blood Pressure Research, Clinical Cardiology, and Epidemiology and Prevention. Circulation 2003, 108:2154-2169. 10.1161/01.CIR.0000095676.90936.80, 14581387, American Heart Association Councils on Kidney in Cardiovascular Disease, High Blood Pressure Research, Clinical Cardiology, and Epidemiology and Prevention.
38. MaCullough PA. Why is chronic kidney disease the " spoiler" for cardiovascular outcomes?. J Am Coll Cardiol 2003, 41:725-728. 10.1016/S0735-1097(02)02955-8, 12628713.
39. Levey AS, Coresh J, Greene T, Stevens LA, Zhang YL, Hendriksen S, Kusek JW, Van Lente F, . Chronic Kidney Disease Epidemiology Collaboration Using standardized serum creatinine values in the modification of diet in renal disease study equation for estimating glomerular filtration rate. Ann Intern Med 2006, 145(4):247-254. Chronic Kidney Disease Epidemiology Collaboration.